GlassScriptPhysician profile
Eugene Marnell
NPI 1275599003
$817.23
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $67.17 · 2021: $123 · 2022: $76.56 · 2023: $29.47 · 2024: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $412.45 | 2019-2024 | Torus Stent Graft System, Endocross Device |
| Cardiva Medical, INC. | $71.25 | 2019-2022 | |
| Lemaitre Vascular, INC. | $46.20 | 2022-2023 | Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $45.88 | 2019-2020 | |
| Medtronic, INC. | $44.64 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $38.62 | 2022-2024 | Artis Pheno |
| Inari Medical, INC. | $36.71 | 2021 | |
| Penumbra, INC. | $34.74 | 2023-2024 | Ruby Coil |
| Boston Scientific Corporation | $29.16 | 2020 | |
| Philips North America LLC | $26.15 | 2020-2021 | |
| Ethicon US, LLC | $16.55 | 2021 | |
| Smith+Nephew, INC. | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Marnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.